The Group's principal activity is that of a Holding Company with interests in the chemical industry. The Group's activities specializes in the development, registration, approval, manufacturing and packaging of pharmaceuticals and generics in Europe and supplier of chemical raw materials, intermediates, specialty chemicals and customized mixtures on the Swiss market. The Group operates through two divisions. Peroral segment includes medications that are administered orally. Parenteral segment includes dosages that are not administered through gastrointestinal tract. The Group operates in Switzerland, Germany, United Kingdom, Ireland, France, Rest of Europe and Rest of World.
Alacra Alerts:
Receive alerts on the latest reports on Acino Holding AG
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
